INCREASED LIFE EXPECTANCY RESULTING FROM ADDITION OF L-DEPRENYL TO MADOPAR TREATMENT IN PARKINSONS-DISEASE - A LONGTERM STUDY

被引：452

作者：

BIRKMAYER, W

KNOLL, J

RIEDERER, P

YOUDIM, MBH

HARS, V

MARTON, J

机构：

[1] SEMMELWEIS UNIV MED,SCH MED,DEPT PHARMACOL,H-1085 BUDAPEST 8,HUNGARY

[2] LAINZ HOSP,LUDWIG BOLTZMANN INST CLIN NEUROBIOL,NEUROCHEM GRP,VIENNA,AUSTRIA

[3] TECHNION FAC MED,RAPPAPORT FAMILY RES INST,DEPT PHARMACOL,HAIFA,ISRAEL

[4] CHINOIN PHARMACEUT & CHEM WORKS LTD,DEPT CLIN RES & BIOMETR,BUDAPEST,HUNGARY

来源：

关键词：

D O I：

10.1007/BF01245973

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：113 / 127

页数：15

共 40 条

[1] MODERN TREATMENT OF PARKINSONISM
BIRKMAYER, W
NEUMAYER, E
[J]. ZEITSCHRIFT FUR NEUROLOGIE, 1972, 202 (04): : 257 - +
[2] POTENTIATION OF ANTI AKINETIC EFFECT AFTER L-DOPA TREATMENT BY AN INHIBITOR OF MAO-B, DEPRENIL
BIRKMAYER, W
RIEDERER, P
YOUDIM, MBH
LINAUER, W
[J]. JOURNAL OF NEURAL TRANSMISSION, 1975, 36 (3-4) : 303 - 326
[3] BIRKMAYER W, 1962, Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr, V203, P560, DOI 10.1007/BF00343235
[4] BIRKMAYER W, 1983, MONOAMINE OXIDASE IT, P170
[5] A PRIMATE MODEL OF PARKINSONISM - SELECTIVE DESTRUCTION OF DOPAMINERGIC-NEURONS IN THE PARS COMPACTA OF THE SUBSTANTIA NIGRA BY N-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE
BURNS, RS
CHIUEH, CC
MARKEY, SP
EBERT, MH
JACOBOWITZ, DM
KOPIN, IJ
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (14): : 4546 - 4550
[6] ETIOLOGY OF PARKINSONS-DISEASE
CALNE, DB
LANGSTON, JW
[J]. LANCET, 1983, 2 (8365) : 1457 - 1459
[7] Cohen G, 1983, J Neural Transm Suppl, V19, P89
[8] CHRONIC PARKINSONISM SECONDARY TO INTRAVENOUS-INJECTION OF MEPERIDINE ANALOGS
DAVIS, GC
WILLIAMS, AC
MARKEY, SP
EBERT, MH
CAINE, ED
REICHERT, CM
KOPIN, IJ
[J]. PSYCHIATRY RESEARCH, 1979, 1 (03) : 249 - 254
[9] DIAMOND SG, 1976, ADV PARKINSONISM, P444
[10] DIXON WJ, 1982, BIOMEDICAL COMPUTE P